Ovarian cancer is characterized by extensive peritoneal metastasis, with tumor spheres commonly found in the malignant ascites. This is associated with poor clinical outcomes and currently lacks effective treatment. Both the three-dimensional (3D) environment and the dynamic mechanical forces are very important factors in this metastatic cascade. However, traditional cell cultures fail to recapitulate this natural tumor microenvironment. Thus, in vivo-like models that can emulate the intraperitoneal environment are of obvious importance. In this study, a new microfluidic platform of the peritoneum was set up to mimic the situation of ovarian cancer spheroids in the peritoneal cavity during metastasis. Ovarian cancer spheroids generated under a non-adherent condition were cultured in microfluidic channels coated with peritoneal mesothelial cells subjected to physiologically relevant shear stress. In summary, this dynamic 3D ovarian cancer-mesothelium microfluidic platform can provide new knowledge on basic cancer biology and serve as a platform for potential drug screening and development.
Introduction
Ovarian cancer is the most lethal gynecological cancer and is characterized by widespread peritoneal dissemination and the formation of malignant ascites 1 . This extensive peritoneal metastasis represents a major clinical challenge and is associated with poor clinical outcomes. Unlike most solid carcinomas that metastasize via the blood, ovarian cancer primarily disseminates within the peritoneal cavity. Tumor cells exist as multicellular aggregates/spheroids during the process of metastasis 2 . The fact that suspension culture can enrich ovarian cancer stem/tumorinitiating cells further suggests that these spheroids may be associated with both tumor aggressiveness and enhanced chemoresistance 3, 4 . There are differences in drug response between 2D and 3D cultures, which presumably have different molecular mechanisms 5 .
The essential interaction with the mesothelium constructs the primary microenvironment for ovarian tumor progression. These mesothelial cells lie on an extracellular matrix (ECM), where fibronectin is a ubiquitous constituent. A link between the increased expression of mesothelial cellderived fibronectin and tumor progression has been shown. Fibronectin is abundantly present in malignant ascites 6, 7 . Ovarian cancer cells are also able to induce the secretion of fibronectin from mesothelial cells in order to promote early ovarian cancer metastasis 8 .
Emerging evidence shows that mechanical stimuli, including shear stress, can modulate cell morphology, gene expression, and, thus, the phenotypes of tumor cells 9, 10, 11 . As malignant ascites develop and accumulate during tumor progression, ovarian tumor cells are exposed to fluid flow and the resulting shear stress. A number of groups, ours included, have shown the impact of shear stress on ovarian cancer progression, including cytoskeleton modifications, epithelial-to-mesenchymal transitions, and cancer stemness 12, 13, 14, 15 . Thus, a physiologically relevant microenvironment is important for the investigation of tumor peritoneal metastasis. However, current in vitro hydrodynamic culture systems have limitations on mimicking and controlling a constant, low, physiologically relevant shear stress 16, 17, 18, 19 . Conventional in vitro approaches focusing on either the cellular or mechanical environment are still limited in mimicking the complexity of the intraperitoneal microenvironment with proper physiological relevance.
1. Microfluidic master design 1. Design and draw the microfluidic channel pattern with any computer-aided design (CAD) software. NOTE: Normally, the CAD drawing can be sent to a photomask company to produce the photomask. The microfluidic design consists of three identical parallel channels, each with the following dimensions: 4 mm × 25 mm × 250 µm (width × length × height) and set 2 mm apart. Both channel ends were designed with 127° angles to facilitate liquid entrance and exit ( Figure 1B) . The channel used in this protocol was reported in a previous publication 13 . 2. Wash the silicon wafer with ultrasonication (500 W/42 kHz) in acetone, isopropanol, and deionized water for 15 min each. Dry the wafer with pressurized nitrogen gas. Heat the silicon wafer on a hot plate at 250 °C for 15 min to completely dry it. 3. Spin-coat a layer of SU-8 2075 photoresist (125 µm-thick) onto the silicon wafer with a spinning speed of 1,800 rpm. Bake the photoresist-coated wafer directly on a hot plate at 65 °C and then at 95 °C, to remove excess solvent, for 5 and 25 min, respectively (according to the SU-8 product manual). 4. Repeat step 3 and spin-coat another layer of SU-8 2075 photoresist to obtain a final thickness of 250 µm. Bake the photoresist-coated wafer directly on a hot plate at 65 °C for 7 min and then at 95 °C for 30 min. Slowly cool the wafer to room temperature. Do not cool with pressurized air. 5. Align and put the photomask directly on top of the wafer. Expose it to UV light for 20 s to crosslink the pattern. 6. Bake the wafer with photoresist at 65 °C and 95 °C on a hotplate for 5 and 12 min, respectively, to remove the solvent for polymerization (according to the SU-8 product manual). Afterwards, cool the wafer to room temperature. 7. Remove the non-crosslinked photoresist by immersing the wafer in SU-8 developer for 25 min. Rinse the wafer with isopropanol and dry it with pressured air. NOTE: If a milky solution was observed when rinsing with isopropanol, indicating incomplete development, immerse the wafer back into SU-8 developer for a longer development time. 8. Place the wafer on a hot plate at 180 °C for 10 min to heal the pattern from potential cracks. Turn off the hot plate and slowly cool down the wafer to room temperature by leaving it on the hot plate. 9. Add a few drops of trichloro (1H, 1H, 2H, 2H-perfluorooctyl) silane in a vial cap. Put the vial cap in the vacuum desiccator. Place the wafer next to the vial cap to silanize the wafer for 10 min.
2. PDMS chip fabrication 1. Wrap the wafer with aluminum foil to create a holder. 2. Mix the polydimethylsiloxane (PDMS) base and curing agent at a 10:1 mass ratio with a centrifugal mixer under the mixing and degas function. Pour the PDMS mixture slowly onto the wafer to a height of around 5 mm. Degas the PDMS under vacuum for 40 min. Cure the PDMS in an oven at 65 °C for 2 h. 3. Carefully peel the PDMS slab off the master and trim the PDMS along the channels until it is the size of a glass slide. Punch the PDMS with a 1-mm biopsy punch to create the inlets and outlets of the device. 4. Clean the PDMS surface with pressurized air and adhesive tape to remove dust and PDMS debris. 5. Place the PDMS slab, with the channel side facing upwards, into a plasma cleaner. Place a clean glass slide into the plasma cleaner alongside the PDMS slab. 6. Treat the PDMS and glass slide under air plasma at high RF level for 1 min. Bind the PDMS to the glass slide to create an irreversible covalent bond. 7. Place the PDMS chip on a hot plate at 150 °C for 1 h to enhance the bonding strength and to return the hydrophobicity of the PDMS before use.
Seeding the Microfluidic Chip with Primary Peritoneal Mesothelial Cells (HPMCs)
1. Fibronectin coating of microfluidic channels 1. Sterilize the microfluidic channel with 30 µL of 75% ethanol. Remove the ethanol and rinse twice with 30 µL of sterilized phosphatebuffered saline (PBS) using a pipette tip. Thoroughly aspirate PBS in the channels. NOTE: To minimize contamination, the microfluidic cell culture should be carefully conducted under fully aseptic conditions through the use of a laminar flow hood. 2. Prepare a 10 µg/mL fibronectin solution in serum-free M199:MCDB105 (1:1) medium. Pipette the solution up and down, with special care to avoid bubble formation. Do not vortex. 3. Slowly fill up each channel with 30 µL of fibronectin solution. Seal the channels with tape and incubate the chip overnight at 4 °C.
2. Seeding HPMCs into the microfluidic channels 1. Culture HPMCs in 10% fetal bovine serum (FBS) culture medium (M199:MCDB105 supplemented with 10% FBS and 100 U/mL penicillin/streptomycin) under 5% CO 2 at 37 °C until 80% confluence. 2. Rinse the HPMCs with 3 mL of PBS and trypsinize with 2 mL of 0.05% trypsin/0.01% EDTA (TE) solution for 30 s. Neutralize with 4 mL of 10% FBS culture medium and spin down the cells at 1,000 x g for 5 min. 
Discussion
This assay offers a flexible and physiologically relevant model that can be incorporated with various biochemical and cell-based assays, including, but not limited to, adhesion assays, mesothelial clearance assays, and drug screening. It can be applied to the evaluation of the effect of the intraperitoneal microenvironment on cancer progression. However, several experimental conditions might need to be optimized, depending on the aims of the project (e.g., the number of HPMCs and cancer spheroids seeded per channel, the co-culture time, etc.). Other cell types in the intraperitoneal microenvironment, such as fibroblasts, endothelial cells, or immune cells, can also be included in the system in order to study the essential interactions between ovarian cancer spheroids and nearby cells. Other ECM components, such as laminin, vitronectin, or collagen, can also be used. One weakness of this protocol that may need to be considered is that, while the coupling of nutrient replenishing and shear stress is reminiscent of that seen in vivo, there is no separate control of nutrient replenishing and shear stress in our current system. Moreover, techniques such as on-chip trypsinization combined with fluorescence-activated cell sorting will be needed to separately collect ovarian cancer cells and HPMCs for further molecular studies about different types of cells.
This technique exhibits several advantages when compared with traditional approaches. First, 3D co-culture better mimics the in vivo intercellular communication between ovarian cancer cells and mesothelial cells. Second, cells are cultured under fluidic flow but are not in static condition, generating a cellular response that is potentially representative of the in vivo situation
